Teachers Advisors’s Aegerion Pharmaceuticals AEGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-39,030
Closed -$144K 3211
2016
Q1
$144K Hold
39,030
﹤0.01% 2878
2015
Q4
$394K Hold
39,030
﹤0.01% 2543
2015
Q3
$531K Hold
39,030
﹤0.01% 2354
2015
Q2
$740K Sell
39,030
-123,838
-76% -$2.68M ﹤0.01% 2293
2015
Q1
$4.26M Buy
162,868
+121,306
+292% +$3.09M 0.01% 1228
2014
Q4
$870K Hold
41,562
﹤0.01% 2108
2014
Q3
$1.39M Hold
41,562
﹤0.01% 1824
2014
Q2
$1.33M Buy
41,562
+13
+0% +$484 ﹤0.01% 1886
2014
Q1
$1.92M Sell
41,549
-139,321
-77% -$8.17M ﹤0.01% 1618
2013
Q4
$12.8M Buy
180,870
+47,018
+35% +$3.6M 0.03% 709
2013
Q3
$11.5M Buy
133,852
+36,585
+38% +$3.1M 0.03% 720
2013
Q2
$6.16M Buy
+97,267
New +$5.16M 0.02% 924

Other funds holding AEGR

Teachers Advisors's AEGR Position: Q2 2016 in Review

Teachers Advisors sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2016, closing a stake of 39,030 shares — an estimated $144K sold.

Teachers Advisors first reported a position in AEGR in Q2 2013 and held it in 12 quarters. The position peaked at $12.8M in Q4 2013. 71 funds tracked by Wall St. Rank hold AEGR as of Q2 2016.

  • Teachers Advisors reported no remaining Aegerion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Teachers Advisors sold 39,030 Aegerion Pharmaceuticals shares in Q2 2016, an estimated $144K.
  • Teachers Advisors first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • Teachers Advisors's Aegerion Pharmaceuticals position peaked at $12.8M in Q4 2013.
  • 71 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2016.

Based on Teachers Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.